Verve Therapeutics, Inc. (VERV)

NASDAQ: VERV · Real-Time Price · USD

4.160

-0.190 (-4.37%)

At close: May 13, 2025, 4:00 PM

4.530

+0.370 (8.89%)

Pre-market: May 14, 2025, 8:35 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Pharmaceutical	32.33M	Log In	Log In
Pharmaceutical Growth	174.98%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	32.33M	Log In	Log In
United States Growth	174.98%	Log In	Log In